Identifying Cladribine prescription pattern in MS: an Italian multicentre study
In our multicentric real-world Italian study, Cladribine therapy is generally effective during the investigated follow-up period. Understanding key characteristics of patients responding best to Cladribine can help tailor therapeutic strategies for optimal outcomes.
Authors
- Diego Centonze (ORCID: https://orcid.org/0000-0002-8390-8545)
- Roberta Fantozzi (ORCID: https://orcid.org/0000-0002-7527-575X)
- Carlo Avolio (ORCID: https://orcid.org/0000-0002-0987-1967)
- Aurora Zanghì (ORCID: https://orcid.org/0000-0002-9566-3135)
- Elisabetta Signoriello (ORCID: https://orcid.org/0000-0001-5753-6752)
- Simona Bonavita (ORCID: https://orcid.org/0000-0002-8561-9720)
- Emanuele D’Amico (ORCID: https://orcid.org/0000-0001-7494-9057)
- Matilde Inglese (ORCID: https://orcid.org/0000-0002-9610-0297)
- Matteo Foschi (ORCID: https://orcid.org/0000-0002-0321-7155)
- Tommaso Sirito (ORCID: https://orcid.org/0000-0002-9016-8709)
- Giacomo Lus (ORCID: https://orcid.org/0000-0002-9457-1124)
- Andrea Surcinelli (ORCID: https://orcid.org/0000-0003-3779-0934)
Institutions
- University of Foggia (IT)
- University of Rome Tor Vergata (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Istituto Neurologico Mediterraneo (IT)
- Azienda Unità Sanitaria Locale Della Romagna (IT)
- University of Genoa (IT)
Publication Details
- Journal
- Therapeutic Advances in Neurological Disorders
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17562864241304212
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47